Chris Fashek is a member of the Board of Directors of Argentum Medical, a Shore Capital portfolio company.
Mr. Fashek is the CEO of Atteris Healthcare, a San Antonio, Texas company formed by Rochal Industries LLC and Catalyst Group, Inc. He also serves as Vice Chairman of Rochal Industries LLC. Atteris commercializes innovative products in the marketplace bringing innovative technologies to patients, clinicians, and providers. Its area of focus is Advanced Wound Care and skin-healing products. Prior to joining Atteris, Chris was the Chairman of the Board and CEO of Spiracur, Inc., a Silicon Valley Startup in the Advanced Wound Care space and KCI where he held the position of Vice Chairman and President of KCI USA.Chris serves on the boards of NanoVibronix, as Chairman, Rochal Industries LLC, as Vice Chairman, World Craniofacial Foundation (WCF), and IDN Summit. He is a subject matter expert in business development, marketing, sales, product development and positioning corporations for hyper-growth and sustainability. He holds his MBA from Fairleigh Dickinson University and Bachelor of Arts in History from Upsala College.